Feature | Cardiovascular Business | November 12, 2021 | By Dave Fornell, DAIC Editor

President Biden Nominates Cardiologist Robert Califf for FDA Commissioner

This is the second time Califf has been nominated to head the FDA

President Joe Biden today announced his intention to nominate cardiologist Robert Califf, M.D., MACC, for the position of commissioner of food and drugs to lead the U.S. Food and Drug Administration (FDA). 

President Joe Biden has nominated cardiologist Robert Califf, M.D., MACC, for the position of commissioner of food and drugs to lead the U.S. Food and Drug Administration (FDA). 

November 12, 2021 — President Joe Biden today announced his intention to nominate cardiologist Robert Califf, M.D., MACC, for the position of commissioner of food and drugs to lead the U.S. Food and Drug Administration (FDA)

He previously served in the commissioner position under the Obama administration between February 2016, and January 20, 2017. Califf, age 70, is currently working as vice chancellor for clinical and translational research at Duke University, and as a senior advisor for Verily Life Sciences and Google Health

His nomination comes when the FDA is facing serious challenges with the continuing COVID-19 pandemic in addition to the normal workload of the agency. His nomination is seen by many in Washington as a way to put an experienced physician who has already performed the job and who has a long history of clinical trial experience in this position. 

"Robert Califf is one of the most experienced clinical trialists in the country, and has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to put an end to the coronavirus pandemic," said President Biden in a statement on the nomination. "As the FDA considers many consequential decisions around vaccine approvals and more, it is mission critical that we have a steady, independent hand to guide the FDA. I am confident Dr. Califf will ensure that the FDA continues its science and data driven decision-making." 

Califf had strong bipartisan support in the Senate during his 2016 confirmation, so Biden is hoping the nominee will have smooth sailing through Congressional approval.

Califf was the founding director of the Duke Clinical Research Institute. He also is a nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality and clinical research. He led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with 1,250 publications in the peer-reviewed literature. 

Califf is a member of the National Academy of Medicine (formerly the Institute of Medicine [IOM]) and served on numerous IOM committees. He was also a member of the FDA Cardio-Renal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. Califf has also served on the Board of Scientific Counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences, and the Council of the National Institute on Aging.

He has led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. 

He served as the principal investigator for Duke's Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center, and as co-principle investigator of the National Patient-Centered Clinical Research Network (PCORnet). 

Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

"Califf is an internationally recognized expert in clinical trial research, health disparities, healthcare quality and cardiovascular medicine. He brings nearly four decades of experience as a doctor, researcher, leader and public servant," Biden said. 


Find More Information on Dr. Robert Califf:

FDA Commissioner Discusses Future of Cardiovascular Medicine

Tsunami of Chronic Health Conditions Expected Due to COVID-19 Disruption of Healthcare

COVID-19 Discussion with Robert Califf

Alphabet taps former FDA commissioner to oversee health strategy and policy

Former FDA Commissioner Robert Califf Will Head Initiatives at Duke, Verily 

Robert M. Califf, MD, MACC, Confirmed as FDA Commissioner (2016)

Related Content

News | Cardiovascular Business

Wishing you a healthy and happy New Year from the DAIC team. Look for many exciting new changes to come in 2022!

Home January 01, 2022
News | Cardiovascular Business

November 10, 2021 — Shockwave Medical, a developer of Intravascular Lithotripsy (IVL) to treat complex calcified ...

Home November 10, 2021
News | Cardiovascular Business

October 15, 2021 — The American Heart Association (AHA) released a new policy statement that offers policy ...

Home October 15, 2021
Feature | Cardiovascular Business

June 10, 2021 — Diagnostic and Interventional Cardiology (DAIC) magazine has won a prestigious Jesse H. Neal Award for ...

Home June 10, 2021
News | Cardiovascular Business

May 5, 2021 — A late-breaking study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) ...

Home May 05, 2021
News | Cardiovascular Business

March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...

Home March 12, 2021
News | Cardiovascular Business

February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral artery ...

Home February 03, 2021
Feature | Cardiovascular Business | Dave Fornell, Editor

December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home December 01, 2020
News | Cardiovascular Business

September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular ...

Home September 14, 2020
Videos | Cardiovascular Business

Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...

Home September 14, 2020
Subscribe Now